Oligoribonucleotides

• 

  Subject Areas on Research

  • Antidote-controlled antithrombotic therapy targeting factor IXa and von Willebrand factor. 
  • Association of 3' terminal RNA sequences with avian leukosis viruses causing a high incidence of osteopetrosis. 
  • Boron-containing aptamers to ATP. 
  • Characterization of the 3' terminus of RNA isolated from vesicular stomatitis virus and from its defective interfering particles. 
  • Cleavage of oligoribonucleotides by a ribozyme derived from the hepatitis delta virus RNA sequence. 
  • Euglena gracilis chloroplast small subunit rRNA. Sequence and base pairing potential of the 3' terminus, cleavage by colicin E3. 
  • In vitro selection of an RNA epitope immunologically cross-reactive with a peptide. 
  • Isolation of 16L virus: a rapidly transforming sarcoma virus from an avian leukosis virus-induced sarcoma. 
  • Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA. 
  • RNA aptamers as reversible antagonists of coagulation factor IXa. 
  • RNA binding by Sxl proteins in vitro and in vivo. 
  • RNA sequence and transcriptional properties of the 3' end of the Newcastle disease virus genome. 
  • Secondary structure of the self-cleaving RNA of hepatitis delta virus: applications to catalytic RNA design. 
  • Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor. 
  • Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide. 
  • The complete sequence of a unique RNA species synthesized by a DI particle of VSV. 
  • Transcription of bacteriophage fl. The major in vivo RNAs.